BDBM398819 1-(trans-4-(3-chlorophenyl)-1- (2-methoxyethyl)pyrrolidin-3- yl)-3-(1',4-dimethyl-1-phenyl- 1H,1'H-[3,4'-bipyrazol]-5- yl)urea::US10323022, Example 296

SMILES COCCN1C[C@@H](NC(=O)Nc2c(C)c(nn2-c2ccccc2)-c2cnn(C)c2)C(C1)c1cccc(Cl)c1

InChI Key InChIKey=BYNOJLHSFRUKFU-WUBHUQEYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 398819   

TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM398819(1-(trans-4-(3-chlorophenyl)-1- (2-methoxyethyl)pyr...)
Affinity DataIC50: <100nMAssay Description:Trk enzymatic selectivity was assessed using Omnia Kinase Assay reagents from Invitrogen Corp. Enzyme (TrkA from Invitrogen Corp.) and test compound ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent